<?xml version='1.0' encoding='utf-8'?>
<document id="18381489"><sentence text="Prediction of pharmacokinetic drug-drug interactions using human hepatocyte suspension in plasma and cytochrome P450 phenotypic data. II. In vitro-in vivo correlation with ketoconazole."><entity charOffset="172-184" id="DDI-PubMed.18381489.s1.e0" text="ketoconazole" /></sentence><sentence text="Traditional cytochrome P450 (P450) based drug-drug interaction (DDI) predictions are based on the ratio of an inhibitor's physiological concentration [I] and its inhibition constant K(i)" /><sentence text=" Determining [I] at the enzymatic site, although critical for predicting clinical DDIs, remains a technical challenge" /><sentence text=" In our previous study, a novel approach using cryopreserved human hepatocytes suspended in human plasma was investigated to mimic the in vivo concentration of ketoconazole at the enzymatic site (Lu et al"><entity charOffset="160-172" id="DDI-PubMed.18381489.s4.e0" text="ketoconazole" /></sentence><sentence text=", 2007), effectively eliminating the estimation of the elusive [I] value" /><sentence text=" P450 inhibition in this system appears to model that in vivo" /><sentence text=" Using the ketoconazole inhibition information in a human hepatocyte-plasma suspension together with quantitative P450 phenotypic information, we successfully predicted the pharmacokinetic DDIs for a small set of drugs, such as theophylline, tolbutamide, omeprazole, desipramine, midazolam, loratadine, cyclosporine, and alprazolam, as well as an investigational compound"><entity charOffset="11-23" id="DDI-PubMed.18381489.s7.e0" text="ketoconazole" /><entity charOffset="228-240" id="DDI-PubMed.18381489.s7.e1" text="theophylline" /><entity charOffset="242-253" id="DDI-PubMed.18381489.s7.e2" text="tolbutamide" /><entity charOffset="255-265" id="DDI-PubMed.18381489.s7.e3" text="omeprazole" /><entity charOffset="267-278" id="DDI-PubMed.18381489.s7.e4" text="desipramine" /><entity charOffset="280-289" id="DDI-PubMed.18381489.s7.e5" text="midazolam" /><entity charOffset="291-301" id="DDI-PubMed.18381489.s7.e6" text="loratadine" /><entity charOffset="303-315" id="DDI-PubMed.18381489.s7.e7" text="cyclosporine" /><entity charOffset="321-331" id="DDI-PubMed.18381489.s7.e8" text="alprazolam" /><pair ddi="false" e1="DDI-PubMed.18381489.s7.e0" e2="DDI-PubMed.18381489.s7.e0" /><pair ddi="false" e1="DDI-PubMed.18381489.s7.e0" e2="DDI-PubMed.18381489.s7.e1" /><pair ddi="false" e1="DDI-PubMed.18381489.s7.e0" e2="DDI-PubMed.18381489.s7.e2" /><pair ddi="false" e1="DDI-PubMed.18381489.s7.e0" e2="DDI-PubMed.18381489.s7.e3" /><pair ddi="false" e1="DDI-PubMed.18381489.s7.e0" e2="DDI-PubMed.18381489.s7.e4" /><pair ddi="false" e1="DDI-PubMed.18381489.s7.e0" e2="DDI-PubMed.18381489.s7.e5" /><pair ddi="false" e1="DDI-PubMed.18381489.s7.e0" e2="DDI-PubMed.18381489.s7.e6" /><pair ddi="false" e1="DDI-PubMed.18381489.s7.e0" e2="DDI-PubMed.18381489.s7.e7" /><pair ddi="false" e1="DDI-PubMed.18381489.s7.e0" e2="DDI-PubMed.18381489.s7.e8" /><pair ddi="false" e1="DDI-PubMed.18381489.s7.e1" e2="DDI-PubMed.18381489.s7.e1" /><pair ddi="false" e1="DDI-PubMed.18381489.s7.e1" e2="DDI-PubMed.18381489.s7.e2" /><pair ddi="false" e1="DDI-PubMed.18381489.s7.e1" e2="DDI-PubMed.18381489.s7.e3" /><pair ddi="false" e1="DDI-PubMed.18381489.s7.e1" e2="DDI-PubMed.18381489.s7.e4" /><pair ddi="false" e1="DDI-PubMed.18381489.s7.e1" e2="DDI-PubMed.18381489.s7.e5" /><pair ddi="false" e1="DDI-PubMed.18381489.s7.e1" e2="DDI-PubMed.18381489.s7.e6" /><pair ddi="false" e1="DDI-PubMed.18381489.s7.e1" e2="DDI-PubMed.18381489.s7.e7" /><pair ddi="false" e1="DDI-PubMed.18381489.s7.e1" e2="DDI-PubMed.18381489.s7.e8" /><pair ddi="false" e1="DDI-PubMed.18381489.s7.e2" e2="DDI-PubMed.18381489.s7.e2" /><pair ddi="false" e1="DDI-PubMed.18381489.s7.e2" e2="DDI-PubMed.18381489.s7.e3" /><pair ddi="false" e1="DDI-PubMed.18381489.s7.e2" e2="DDI-PubMed.18381489.s7.e4" /><pair ddi="false" e1="DDI-PubMed.18381489.s7.e2" e2="DDI-PubMed.18381489.s7.e5" /><pair ddi="false" e1="DDI-PubMed.18381489.s7.e2" e2="DDI-PubMed.18381489.s7.e6" /><pair ddi="false" e1="DDI-PubMed.18381489.s7.e2" e2="DDI-PubMed.18381489.s7.e7" /><pair ddi="false" e1="DDI-PubMed.18381489.s7.e2" e2="DDI-PubMed.18381489.s7.e8" /><pair ddi="false" e1="DDI-PubMed.18381489.s7.e3" e2="DDI-PubMed.18381489.s7.e3" /><pair ddi="false" e1="DDI-PubMed.18381489.s7.e3" e2="DDI-PubMed.18381489.s7.e4" /><pair ddi="false" e1="DDI-PubMed.18381489.s7.e3" e2="DDI-PubMed.18381489.s7.e5" /><pair ddi="false" e1="DDI-PubMed.18381489.s7.e3" e2="DDI-PubMed.18381489.s7.e6" /><pair ddi="false" e1="DDI-PubMed.18381489.s7.e3" e2="DDI-PubMed.18381489.s7.e7" /><pair ddi="false" e1="DDI-PubMed.18381489.s7.e3" e2="DDI-PubMed.18381489.s7.e8" /><pair ddi="false" e1="DDI-PubMed.18381489.s7.e4" e2="DDI-PubMed.18381489.s7.e4" /><pair ddi="false" e1="DDI-PubMed.18381489.s7.e4" e2="DDI-PubMed.18381489.s7.e5" /><pair ddi="false" e1="DDI-PubMed.18381489.s7.e4" e2="DDI-PubMed.18381489.s7.e6" /><pair ddi="false" e1="DDI-PubMed.18381489.s7.e4" e2="DDI-PubMed.18381489.s7.e7" /><pair ddi="false" e1="DDI-PubMed.18381489.s7.e4" e2="DDI-PubMed.18381489.s7.e8" /><pair ddi="false" e1="DDI-PubMed.18381489.s7.e5" e2="DDI-PubMed.18381489.s7.e5" /><pair ddi="false" e1="DDI-PubMed.18381489.s7.e5" e2="DDI-PubMed.18381489.s7.e6" /><pair ddi="false" e1="DDI-PubMed.18381489.s7.e5" e2="DDI-PubMed.18381489.s7.e7" /><pair ddi="false" e1="DDI-PubMed.18381489.s7.e5" e2="DDI-PubMed.18381489.s7.e8" /><pair ddi="false" e1="DDI-PubMed.18381489.s7.e6" e2="DDI-PubMed.18381489.s7.e6" /><pair ddi="false" e1="DDI-PubMed.18381489.s7.e6" e2="DDI-PubMed.18381489.s7.e7" /><pair ddi="false" e1="DDI-PubMed.18381489.s7.e6" e2="DDI-PubMed.18381489.s7.e8" /><pair ddi="false" e1="DDI-PubMed.18381489.s7.e7" e2="DDI-PubMed.18381489.s7.e7" /><pair ddi="false" e1="DDI-PubMed.18381489.s7.e7" e2="DDI-PubMed.18381489.s7.e8" /></sentence><sentence text=" For the applicability of this model on a wider scale the in vitro-in vivo correlation data set needed to be expanded" /><sentence text=" However, for most drugs in the literature there is not enough quantitative information on the involvement of individual P450s to predict DDIs retrospectively" /><sentence text=" To facilitate that, in this study we determined quantitative P450 phenotyping for seven marketed drugs: budesonide, buprenorphine, loratadine, sirolimus, tacrolimus, docetaxel, and methylprednisolone"><entity charOffset="105-115" id="DDI-PubMed.18381489.s10.e0" text="budesonide" /><entity charOffset="117-130" id="DDI-PubMed.18381489.s10.e1" text="buprenorphine" /><entity charOffset="132-142" id="DDI-PubMed.18381489.s10.e2" text="loratadine" /><entity charOffset="144-153" id="DDI-PubMed.18381489.s10.e3" text="sirolimus" /><entity charOffset="155-165" id="DDI-PubMed.18381489.s10.e4" text="tacrolimus" /><entity charOffset="167-176" id="DDI-PubMed.18381489.s10.e5" text="docetaxel" /><entity charOffset="182-200" id="DDI-PubMed.18381489.s10.e6" text="methylprednisolone" /><pair ddi="false" e1="DDI-PubMed.18381489.s10.e0" e2="DDI-PubMed.18381489.s10.e0" /><pair ddi="false" e1="DDI-PubMed.18381489.s10.e0" e2="DDI-PubMed.18381489.s10.e1" /><pair ddi="false" e1="DDI-PubMed.18381489.s10.e0" e2="DDI-PubMed.18381489.s10.e2" /><pair ddi="false" e1="DDI-PubMed.18381489.s10.e0" e2="DDI-PubMed.18381489.s10.e3" /><pair ddi="false" e1="DDI-PubMed.18381489.s10.e0" e2="DDI-PubMed.18381489.s10.e4" /><pair ddi="false" e1="DDI-PubMed.18381489.s10.e0" e2="DDI-PubMed.18381489.s10.e5" /><pair ddi="false" e1="DDI-PubMed.18381489.s10.e0" e2="DDI-PubMed.18381489.s10.e6" /><pair ddi="false" e1="DDI-PubMed.18381489.s10.e1" e2="DDI-PubMed.18381489.s10.e1" /><pair ddi="false" e1="DDI-PubMed.18381489.s10.e1" e2="DDI-PubMed.18381489.s10.e2" /><pair ddi="false" e1="DDI-PubMed.18381489.s10.e1" e2="DDI-PubMed.18381489.s10.e3" /><pair ddi="false" e1="DDI-PubMed.18381489.s10.e1" e2="DDI-PubMed.18381489.s10.e4" /><pair ddi="false" e1="DDI-PubMed.18381489.s10.e1" e2="DDI-PubMed.18381489.s10.e5" /><pair ddi="false" e1="DDI-PubMed.18381489.s10.e1" e2="DDI-PubMed.18381489.s10.e6" /><pair ddi="false" e1="DDI-PubMed.18381489.s10.e2" e2="DDI-PubMed.18381489.s10.e2" /><pair ddi="false" e1="DDI-PubMed.18381489.s10.e2" e2="DDI-PubMed.18381489.s10.e3" /><pair ddi="false" e1="DDI-PubMed.18381489.s10.e2" e2="DDI-PubMed.18381489.s10.e4" /><pair ddi="false" e1="DDI-PubMed.18381489.s10.e2" e2="DDI-PubMed.18381489.s10.e5" /><pair ddi="false" e1="DDI-PubMed.18381489.s10.e2" e2="DDI-PubMed.18381489.s10.e6" /><pair ddi="false" e1="DDI-PubMed.18381489.s10.e3" e2="DDI-PubMed.18381489.s10.e3" /><pair ddi="false" e1="DDI-PubMed.18381489.s10.e3" e2="DDI-PubMed.18381489.s10.e4" /><pair ddi="false" e1="DDI-PubMed.18381489.s10.e3" e2="DDI-PubMed.18381489.s10.e5" /><pair ddi="false" e1="DDI-PubMed.18381489.s10.e3" e2="DDI-PubMed.18381489.s10.e6" /><pair ddi="false" e1="DDI-PubMed.18381489.s10.e4" e2="DDI-PubMed.18381489.s10.e4" /><pair ddi="false" e1="DDI-PubMed.18381489.s10.e4" e2="DDI-PubMed.18381489.s10.e5" /><pair ddi="false" e1="DDI-PubMed.18381489.s10.e4" e2="DDI-PubMed.18381489.s10.e6" /><pair ddi="false" e1="DDI-PubMed.18381489.s10.e5" e2="DDI-PubMed.18381489.s10.e5" /><pair ddi="false" e1="DDI-PubMed.18381489.s10.e5" e2="DDI-PubMed.18381489.s10.e6" /></sentence><sentence text=" Augmentation of the new data set with the one generated previously produced broader a database that provided further support for the wider applicability of this approach using ketoconazole as a potent CYP3A inhibitor"><entity charOffset="177-189" id="DDI-PubMed.18381489.s11.e0" text="ketoconazole" /></sentence><sentence text=" This application is predicted to be equally effective with other P450 inhibitors that are not substrates of efflux pumps" /><sentence text="" /></document>